Intravenous pamidronate increases bone density in postmenopausal women previously treated with oral bisphosphonates.

被引：0
|
作者：
Rastelli, A [1 ]
Napoli, N [1 ]
Civitelli, R [1 ]
机构：
[1] Washington Univ, Div Bone & Mineral Dis, St Louis, MO USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2003年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [41] Bone mineral density variations in postmenopausal women treated with teriparatide
    Osorio, F.
    Barata, S.
    Pauleta, J.
    Santo, S.
    Neves, J.
    Pereira-Coelho, A.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S270 - S270
  • [42] Teriparatide reduces bone microdamage accumulation in postmenopausal women previously treated with alendronate
    Dobnig, H.
    Stepan, J. J.
    Burr, D. B.
    Fahrleitner-Pammer, A. F.
    Li, J.
    Sipos, A.
    Sato, M.
    Pavo, I.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S28 - S28
  • [43] Teriparatide Reduces Bone Microdamage Accumulation in Postmenopausal Women Previously Treated With Alendronate
    Dobnig, Harald
    Stepan, Jan J.
    Burr, David B.
    Li, Jiliang
    Michalska, Dana
    Sipos, Adrien
    Petto, Helmut
    Fahrleitner-Pammer, Astrid
    Pavo, Imre
    JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (12) : 1998 - 2006
  • [44] The effect of oral alendronate versus intravenous pamidronate on bone mineral density in patients with osteoporosis.
    Vis, M
    Bultink, I
    Dijkmans, B
    Lems, W
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S311 - S311
  • [45] A RANDOMIZED DOUBLE-BLIND STUDY OF DENOSUMAB (DMAB) COMPARED WITH ZOLEDRONIC ACID (ZOL) IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS PREVIOUSLY TREATED WITH ORAL BISPHOSPHONATES
    Miller, P.
    Pannacciulli, N.
    Brown, J. P.
    Czerwinski, E.
    Nedergaard, B. S.
    Bolognese, M. A.
    Malouf, J.
    Bones, H. G.
    Reginster, J. -Y.
    Singer, A.
    Wang, C.
    Wagman, R. B.
    Cummings, S. R.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S41 - S41
  • [46] The effect of oral alendronate versus intravenous pamidronate in the effect on bone mineral density in patients with osteoporosis
    Vis, M
    Bultink, IE
    Dijkmans, BAC
    Lems, WF
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 460 - 460
  • [47] Effect of Rheumatoid Arthritis on Volumetric Bone Mineral Density and Bone Geometry, Assessed by Peripheral Quantitative Computed Tomography in Postmenopausal Women Treated with Bisphosphonates
    Tournis, Symeon
    Samdanis, Vasilios
    Psarelis, Savas
    Liakou, Chrysa
    Antoniou, Julia
    Georgoulas, Thomas
    Dontas, Ismini
    Papaioannou, Nikolaos
    Gazi, Susan
    Lyritis, George P.
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (06) : 1215 - 1220
  • [48] Oral Bisphosphonates and Breast Cancer Incidence in postmenopausal Women
    Solomayer, E. -F.
    Rody, A.
    ONKOLOGE, 2011, 17 (06): : 536 - 537
  • [49] PHYSICAL EXERCISE INCREASES BONE-MINERAL DENSITY IN POSTMENOPAUSAL WOMEN
    SHIMEGI, S
    YANAGITA, M
    OKANO, H
    YAMADA, M
    FUKUI, H
    FUKUMURA, Y
    IBUKI, Y
    KOJIMA, I
    ENDOCRINE JOURNAL, 1994, 41 (01) : 49 - 56
  • [50] Serum carboxyterminal telopeptide (ICTP) as a prognostic marker in bone metastases (BM) treated with bisphosphonates.
    Costa, L.
    Carvalho, R.
    Oliveira, A. G.
    Bicho, M.
    Fernandes, A.
    Rodrigues, T.
    Ali, S.
    Leitzel, K.
    Demers, L.
    Lipton, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 567S - 567S
12345